Mammographic Density Clinical Trial
Official title:
A Single Dose Trial to Evaluate the Pharmacokinetics of Testosterone and Anastrozole From Subcutaneous Testosterone and Anastrozole (T+Ai) in Premenopausal Women
A single dose trial to evaluate the pharmacokinetics of testosterone and anastrozole from subcutaneous testosterone and anastrozole (T+Ai) in premenopausal women
The trial is of open label single centre design. The serum concentrations of testosterone and plasma concentrations of anastrozole will be measured in 12 premenopausal women. Participants will be stratified in a 50:50 manner in two BMI (Body Mass Index) groups, <25 and 25 kg/m2, respectively. There will be a lead group of two participants in whom the serum/plasma concentrations will be examined after the first four weeks, to determine whether the sampling schedule adequately describes the serum/plasma concentration-time profiles or should be adjusted. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02524561 -
KEEPS Mammographic Density And Breast Health Ancillary Study
|
N/A | |
| Enrolling by invitation |
NCT03686098 -
The Malaysian Soy and Mammographic Density Study
|
N/A | |
| Completed |
NCT04096469 -
Impact of Diet and Physical Activity Changes on Body Weight, Biomarkers and Quality of Life in Breast Cancer Survivors
|
N/A | |
| Completed |
NCT04079517 -
Karolinska Interventional Study of Mammograhic Density (Karisma-1)
|
Phase 1/Phase 2 | |
| Completed |
NCT03629717 -
RANKL Inhibition and Breast Tissue Biomarkers
|
Early Phase 1 | |
| Completed |
NCT03264651 -
Enobosarm and Anastrozole in Pre-menopausal Women With High Mammographic Breast Density
|
Phase 1 | |
| Not yet recruiting |
NCT03696147 -
Diffusion Magnetic Resonance Imaging in Mamographically Detected Asymmetric Densities
|